Transforming Growth Factor Beta-Induced (TGFBI) Is an Anti-Adhesive Protein Regulating the Invasive Growth of Melanoma Cells

Autor: Johanna Soikkeli, Erkki Hölttä, Olli Saksela, Pirjo Nummela, Johanna Lammi, Pirjo Laakkonen
Rok vydání: 2012
Předmět:
Talin
Pathology
medicine.medical_specialty
Mice
Nude

Biology
Periostin
Pathology and Forensic Medicine
Extracellular matrix
Mice
03 medical and health sciences
0302 clinical medicine
Cell Movement
Transforming Growth Factor beta
Cell Adhesion
Tumor Cells
Cultured

medicine
Animals
Humans
Neoplasm Invasiveness
Melanoma
Skin
030304 developmental biology
Extracellular Matrix Proteins
Mice
Inbred BALB C

0303 health sciences
Matrigel
Integrin beta1
Transforming growth factor beta
Fibroblasts
medicine.disease
Recombinant Proteins
eye diseases
Extracellular Matrix
Neoplasm Proteins
Up-Regulation
Gene Expression Regulation
Neoplastic

Thymosin
Fibronectin
Actin Cytoskeleton
Gene Knockdown Techniques
030220 oncology & carcinogenesis
biology.protein
Cancer research
Female
Neoplasm Transplantation
Genome-Wide Association Study
TGFBI
Transforming growth factor
Zdroj: The American Journal of Pathology; Vol 180
ISSN: 0002-9440
DOI: 10.1016/j.ajpath.2011.12.035
Popis: Melanoma is a malignancy characterized by high invasive/metastatic potential, with no efficient therapy after metastasis. Understanding the molecular mechanisms underlying the invasive/metastatic tendency is therefore important. Our genome-wide gene expression analyses revealed that human melanoma cell lines WM793 and especially WM239 (vertical growth phase and metastatic cells, respectively) overexpress the extracellular matrix (ECM) protein transforming growth factor β induced (TGFBI). In adhesion assays, recombinant TGFBI was strongly anti-adhesive for both melanoma cells and skin fibroblasts. TGFBI further impaired the adhesion of melanoma cells to the adhesive ECM proteins fibronectin, collagen-I, and laminin, known to interact with it. Unexpectedly, WM239 cells migrated/invaded more effectively in three-dimensional collagen-I and Matrigel cultures after knockdown of TGFBI by shRNA expression. However, in the physiological subcutaneous microenvironment in nude mice, after TGFBI knockdown, these cells showed markedly impaired tumor growth and invasive capability; the initially formed small tumors later underwent myxoid degeneration and completely regressed. By contrast, the expanding control tumors showed intense TGFBI staining at the tumor edges, co-localizing with the fibrillar fibronectin/tenascin-C/periostin structures that characteristically surround melanoma cells at invasion fronts. Furthermore, TGFBI was found in similar fibrillar structures in clinical human melanoma metastases as well, co-localizing with fibronectin. These data imply an important role for TGFBI in the ECM deposition and invasive growth of melanoma cells, rendering TGFBI a potential target for therapeutic interventions.
Databáze: OpenAIRE